Practice-Influential Trials Reach 82 and 14 Drug Approvals
Research Impact
2024
By 2024, SWOG-led research had produced 82+ practice-influential trials and contributed to 14 FDA cancer drug approvals—representing over six decades of network-wide research that has fundamentally transformed how cancer is treated worldwide.
Recent Breakthroughs
15-Year Results from SWOG’s S0016 Study Suggest Follicular Lymphoma Is Curable
A new long-term study challenges the belief that advanced follicular lymphoma is...
SWOG Cancer Research Network Celebrates 70 Years
SWOG Cancer Research Network marks its 70th year having enrolled nearly a...
New Immunotherapy Combination Standard for Hodgkin Lymphoma
The SWOG S1826 trial established nivolumab plus AVD chemotherapy as the new...
30 Years of Supporting SWOG and Advancing Cancer Care
In 2023, The Hope Foundation honored its 30 years of support for...
Let’s advance cancer research, together.
Since our founding in 1993, we’ve harnessed answers to cancers through clinical trials. Join us to fuel the latest and best - or peruse our programs to apply for funding.
Robert Krouse, MD
Co-Chair, SWOG Palliative Care Committee